Chester County News and Community Website
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced that the European Commission has granted Advanced Therapy Medicinal Product (ATMP) classifications for its gene therapies OCU410 and OCU410ST. This regulatory milestone …
Ocugen Secures ATMP Classification for Gene Therapies Targeting Vision Loss Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has reached a significant milestone in the development of a groundbreaking treatment for geographic atrophy (GA), an advanced form of dry age-related macular …
Ocugen Advances in Revolutionary Gene Therapy for Age-Related Macular Degeneration Read More
HORSHAM, PA — In observance of January as Glaucoma Awareness Month, Medical Optometry America (MOA) is underscoring its dedication to battling glaucoma, a foremost contributor to irreversible vision loss and …
Combating the ‘Silent Thief of Sight’: MOA Takes Aim at Glaucoma Read More